9, rue d'Enghien
Paris 75010
France
33 1 48 24 03 45
https://www.maunakeatech.com
Sector(s):
Industry:
Full-time employees: 68
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Alexandre Loiseau Ph.D. | Co-Founder, CEO & Chairman | 172.64k | N/A | N/A |
Mr. Come de La Tour du Pin | Chief Financial Officer | N/A | N/A | N/A |
Ms. Nathalie Lecoq | Chief Operating Officer | N/A | N/A | N/A |
Mr. Frederic Banegas Ph.D. | Chief Technology Officer | N/A | N/A | N/A |
Mr. François Lacombe Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Mr. Daryl Donatelli | Vice President of Global Marketing & U.S. Sales | N/A | N/A | N/A |
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Mauna Kea Technologies SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.